Mr Mrs Miss Ms Dr Other

Mrs
Karen
Russell

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. [email protected]
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

Bringing over 20 years’ experience in private practice, Karen specialises in the fields of life sciences and pharmaceuticals. Having started her career in London, she joined HGF in 2010 and enjoys being an active member of the biotech and chemical teams in the Manchester office.

Karen’s experience covers a wide range of biotechnological and biopharmaceutical subject matter including nucleic acid and peptide based therapeutics. She has a particular interest in SPCs, and her practice includes filing and prosecution of SPC applications in both the medicinal and agrochemical fields.

In the course of her career, she has worked with a variety of clients, including universities, SMEs and large multi-nationals, providing guidance in patent prosecution before the EPO and internationally, as well as advice relating to patentability, freedom to operate, and SPC filings.

Karen holds an MA in Natural Sciences (Biological), and an MPhil in Biotechnology, both from the University of Cambridge. Her MPhil research investigated the genetic basis for the microbial degradation of cocaine.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MA

Natural Sciences (Cantab)

POSTGRADUATE DIPLOMA OR CERTIFICATE

Queen Mary and Westfield College Certificate in Intellectual Property Law

OTHER

MPhil Biotechnology (Cantab)

Publications

A Step Towards A Unitary SPC?

View publication online

EU SPC waiver for generic pharmaceuticals producers

View publication online

Related News

Can Patent Box Help Keep The Lights On?

The UK energy sector is undergoing a transformative shift, with innovations in renewable energy, carbon capture, and advanced drilling technologies driving progress. Patent Box, a tax relief scheme introduced in …

Read article

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Patent applications and grants in Europe

HGF is pleased to invite you to our upcoming German-language seminar on “Patent applications and grants in Europe” in Salzburg and Dresden. The seminar provides participants with a comprehensive overview …

Event details
Event - 10th October 2024

Webinar: Patents and business activities in harmony

In today’s highly competitive world, patents are not only a legal tool but also a strategic instrument to strengthen your market position and maximise your business success. But how do …

Event details
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

Event details

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.